High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation
Open Access
- 2 November 2016
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 7 (5) , e01530-16
Abstract
The major transformation activity of the high-risk human papillomaviruses (HPV) is associated with the E7 oncoprotein. The interaction of HPV E7 with retinoblastoma family proteins is important for several E7 activities; however, this interaction does not fully account for the high-risk E7-specific cellular immortalization and transformation activities. We have determined that the cellular non-receptor protein tyrosine phosphatase PTPN14 interacts with HPV E7 from many genus alpha and beta HPV types. We find that high-risk genus alpha HPV E7, but not low-risk genus alpha or beta HPV E7, is necessary and sufficient to reduce the steady-state level of PTPN14 in cells. High-risk E7 proteins target PTPN14 for proteasome-mediated degradation, which requires the ubiquitin ligase UBR4, and PTPN14 is degraded by the proteasome in HPV-positive cervical cancer cell lines. Residues in the C terminus of E7 interact with the C-terminal phosphatase domain of PTPN14, and interference with the E7-PTPN14 interaction restores PTPN14 levels in cells. Finally, PTPN14 degradation correlates with the retinoblastoma-independent transforming activity of high-risk HPV E7. IMPORTANCE High-risk human papillomaviruses (HPV) are the cause of cervical cancer, some other anogenital cancers, and a growing fraction of oropharyngeal carcinomas. The high-risk HPV E6 and E7 oncoproteins enable these viruses to cause cancer, and the mechanistic basis of their carcinogenic activity has been the subject of intense study. The high-risk E7 oncoprotein is especially important in the immortalization and transformation of human cells, which makes it a central component of HPV-associated cancer development. E7 oncoproteins interact with retinoblastoma family proteins, but for several decades, it has been recognized that high-risk HPV E7 oncoproteins have additional cancer-associated activities. We have determined that high-risk E7 proteins target the proteolysis of the cellular protein tyrosine phosphatase PTPN14 and find that this activity is correlated with the retinoblastoma-independent transforming activity of E7.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (R35CA197262)
- Alexander and Margaret Stewart Trust
This publication has 67 references indexed in Scilit:
- PTPN14 is required for the density-dependent control of YAP1Genes & Development, 2012
- Interpreting cancer genomes using systematic host network perturbations by tumour virus proteinsNature, 2012
- Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomavirusesProceedings of the National Academy of Sciences, 2012
- Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikisGenes & Development, 2012
- Regulation of cellular miRNA expression by human papillomavirusesBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2011
- Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expressionProceedings of the National Academy of Sciences, 2010
- Small DNA tumor viruses: Large contributors to biomedical sciencesVirology, 2009
- Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Cullin 2 Ubiquitin Ligase Complex, Which Contributes to Degradation of the Retinoblastoma Tumor SuppressorJournal of Virology, 2007
- Protein tyrosine phosphatases: from genes, to function, to diseaseNature Reviews Molecular Cell Biology, 2006
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003